These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38715012)

  • 1. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
    Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
    Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0005576 promotes osimertinib resistance through the miR-512-5p/IGF1R axis in lung adenocarcinoma cells.
    Liu S; Jiang Z; Xiao P; Li X; Chen Y; Tang H; Chai Y; Liu Y; Zhu Z; Xie Q; He W; Ma Y; Jin L; Feng W
    Cancer Sci; 2022 Jan; 113(1):79-90. PubMed ID: 34706132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation.
    Hayakawa D; Takahashi F; Mitsuishi Y; Tajima K; Hidayat M; Winardi W; Ihara H; Kanamori K; Matsumoto N; Asao T; Ko R; Shukuya T; Takamochi K; Hayashi T; Suehara Y; Takeda Nakamura I; Ueno T; Kohsaka S; Mano H; Takahashi K
    Thorac Cancer; 2020 Jan; 11(1):140-149. PubMed ID: 31758670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis.
    Jiang Z; Yin J; Peng G; Long X
    Anticancer Drugs; 2021 Jan; 32(1):1-10. PubMed ID: 32932275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer.
    Li Y; Wang N; Huang Y; He S; Bao M; Wen C; Wu L
    Cancer Genet; 2024 Jun; 284-285():34-42. PubMed ID: 38626533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
    Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
    Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
    Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
    Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.
    Wu Y; Xie J; Wang H; Hou S; Feng J
    J Clin Lab Anal; 2022 May; 36(5):e24408. PubMed ID: 35396749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
    Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
    Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
    Wei D; Sun L; Feng W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0000003 promotes the proliferation and metastasis of non-small cell lung cancer cells via miR-338-3p/insulin receptor substrate 2.
    Li S; Niu X; Li H; Liang Y; Sun Z; Yan Y
    Cell Cycle; 2019 Dec; 18(24):3525-3539. PubMed ID: 31736412
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression.
    Li L; Liu D; Chen T; Wei C; Qiao Y; Liu W; Liang Y; Liang Z; Chen C; Li D; Wu B; Zhao X; Huang D; Wu D
    J Exp Clin Cancer Res; 2024 Jul; 43(1):200. PubMed ID: 39030638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircRNA circ_0008037 facilitates tumor growth and the Warburg effect via upregulating NUCKS1 by binding to miR-433-3p in non-small cell lung cancer.
    Yu J; Zhang H; Zhao C; Li G; Zhang Y; Sun Y
    Thorac Cancer; 2022 Jan; 13(2):162-172. PubMed ID: 34850570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0072309 inhibits non-small cell lung cancer progression by sponging miR-580-3p.
    Pang W; Huang F; Zhang X; Ye M; Huang Y; Huang X; Pang J; Cai C; Wang Z
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32293004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
    Wen XP; Ma HL; Zhao LY; Zhang W; Dang CX
    Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):78-85. PubMed ID: 26025408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
    Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
    Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C
    Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.